Viewing Study NCT06845202

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:02 AM
Ignite Modification Date: 2026-01-28 @ 8:48 PM
Study NCT ID: NCT06845202
Status: RECRUITING
Last Update Posted: 2025-12-19
First Post: 2025-02-20
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DM
Sponsor: Alnylam Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Obese or Overweight Healthy Volunteers View
None Type 2 Diabetes Mellitus (T2DM) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None siRNA View
None RNAi therepeutic View